vaccines

A broad defense against SARS-like virusesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the third coronavirus that has emerged as a serious human pathogen in the past 20 years. Treatment strategies that are broadly…

Therapeutic proteins such as vaccines, antibodies, hormones, and cytokines are generally produced in bacteria or eukaryotic systems, including chicken eggs and mammalian or insect cell cultures, with high production yield according to…

SummaryCertain virtues of the messenger RNA (mRNA) vaccines made by the Pfizer-BioNTech collaboration and Moderna—like others authorized for emergency use in the coronavirus pandemic—are well known and documented: They prevent symptomatic…

SummaryOther than a placebo-controlled, clinical trial lasting many months and involving tens of thousands of people, is there any way to be sure a COVID-19 vaccine will work? Many researchers say the vaccines already in use offers a…

Science's COVID-19 reporting is supported by the Heising-Simons FoundationA nursing home worker in the Netherlands gets a COVID-19 vaccine. A Dutch database lies at the heart of a controversy around a paper on vaccine safety.PHOTO:…

AbstractThe inclusion of infants in the SARS-CoV-2 vaccine roll-out is important to prevent severe complications of pediatric SARS-CoV-2 infections and to limit transmission and could possibly be implemented via the global pediatric vaccine…

Science's COVID-19 reporting is supported by the Heising-Simons FoundationFaced with short supplies of COVID-19 vaccines and unforeseen side effects, some countries have adopted an unproven strategy: switching shots midstream. Most…